Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

49 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The role of non-coding genome in the behavior of infiltrated myeloid-derived suppressor cells in tumor microenvironment; a perspective and state-of-the-art in cancer targeted therapy.
Shabgah AG, Salmaninejad A, Thangavelu L, Alexander M, Yumashev AV, Goleij P, Hedayati-Moghadam M, Mohammadi H, Ahmadi M, Navashenaq JG. Shabgah AG, et al. Among authors: navashenaq jg. Prog Biophys Mol Biol. 2021 May;161:17-26. doi: 10.1016/j.pbiomolbio.2020.11.006. Epub 2020 Nov 28. Prog Biophys Mol Biol. 2021. PMID: 33259833 Review.
Immunomodulatory effects of nanocurcumin on Th17 cell responses in mild and severe COVID-19 patients.
Tahmasebi S, El-Esawi MA, Mahmoud ZH, Timoshin A, Valizadeh H, Roshangar L, Varshoch M, Vaez A, Aslani S, Navashenaq JG, Aghebati-Maleki L, Ahmadi M. Tahmasebi S, et al. Among authors: navashenaq jg. J Cell Physiol. 2021 Jul;236(7):5325-5338. doi: 10.1002/jcp.30233. Epub 2020 Dec 28. J Cell Physiol. 2021. Retraction in: J Cell Physiol. 2024 Nov;239(11):e31356. doi: 10.1002/jcp.31356 PMID: 33372280 Retracted.
Nanocurcumin improves Treg cell responses in patients with mild and severe SARS-CoV2.
Tahmasebi S, Saeed BQ, Temirgalieva E, Yumashev AV, El-Esawi MA, Navashenaq JG, Valizadeh H, Sadeghi A, Aslani S, Yousefi M, Jadidi-Niaragh F, Adigozalou J, Ahmadi M, Roshangar L. Tahmasebi S, et al. Among authors: navashenaq jg. Life Sci. 2021 Jul 1;276:119437. doi: 10.1016/j.lfs.2021.119437. Epub 2021 Mar 28. Life Sci. 2021. PMID: 33789145 Free PMC article.
Expression of concern: "Humoral immune mechanisms involved in protective and pathological immunity during COVID-19" [Hum. Immunol. 82(10) (2021) 733-745].
Widjaja G, Jalil AT, Rahman HS, Abdelbasset WK, Bokov DO, Bokov DO, Ghaebi M, Marofi F, Navashenaq JG, Jadidi-Niaragh F, Ahmadi M. Widjaja G, et al. Among authors: navashenaq jg. Hum Immunol. 2023 May-Jul;84(5-7):355. doi: 10.1016/j.humimm.2023.03.005. Epub 2023 Apr 8. Hum Immunol. 2023. PMID: 37271569 Free PMC article. No abstract available.
Interleukin-22 in human inflammatory diseases and viral infections.
Shabgah AG, Navashenaq JG, Shabgah OG, Mohammadi H, Sahebkar A. Shabgah AG, et al. Among authors: navashenaq jg. Autoimmun Rev. 2017 Dec;16(12):1209-1218. doi: 10.1016/j.autrev.2017.10.004. Epub 2017 Oct 14. Autoimmun Rev. 2017. PMID: 29037907 Review.
49 results